专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
今天看啥  ›  专栏  ›  毕凯今选

【其他高分选 075】

毕凯今选  · 公众号  ·  · 2024-11-15 12:46

文章预览

BC PMID: 39499997 IF:15.8 Fasting-mimicking diet potentiates anti-tumor effects of CDK4/6 inhibitors against breast cancer by suppressing NRAS- and IGF1-mediated mTORC1 signaling SCI:Drug Resist Updat PMID:39500869 IF:14.7 Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer SCI:Nat Commun PMID:39504368 IF:11.7 Mitochondrial elongation impairs breast cancer metastasis SCI:Sci Adv PMID:39502841 IF:18 Scaffolds functionalized with matrix metalloproteinase-responsive release of miRNA for synergistic magnetic hyperthermia and sensitizing chemotherapy of drug-tolerant breast cancer SCI:Bioact Mater PMID:39505147 IF:11.4 Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer SCI:J Adv Res PMID:39506069 IF:81.1 Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now? SCI:Nat Rev Clin Oncol PMID:39506777 IF:10.6 Cascade-catalysed nan ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览